Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC.EGRX · Entity 85958 | Director | March 07, 2023 | March 09, 2023 |
| INSULET CORPPODD · Entity 3516 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EAGLE PHARMACEUTICALS, INC.
Report date March 07, 2023 · Filed March 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.00 · Expires 2033-03-07 | Direct | 16,253 |
Reported balance
After 2023-03-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-07 · Grant · Acquired 16,253 · Balance 16,253 F1: The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.
INSULET CORP
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,329 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Sale · Disposed 418 · Balance 4,329 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:23 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 418 | $143.27 | $59,886.86 |
DisclosureSEC source: 0001145197-26-000142 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,329 Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:29 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001145197-26-000122 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,747 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2027. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 20:17 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 481 | $305.73 | $147,056.13 |
DisclosureSEC source: 0001127602-25-017205 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,087 Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:03 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015640 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,568 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2026. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:01 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 508 | $274.80 | $139,598.40 |
DisclosureSEC source: 0001127602-24-027203 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,790 Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 20:13 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 360 | $182.58 | $65,728.80 |
DisclosureSEC source: 0001127602-24-017915 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,298 Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:05 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016455 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,658 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2025 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:01 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 72 | $207.08 | $14,909.76 |
DisclosureSEC source: 0001127602-23-029804 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,278 Read SEC document |
| June 05, 2023 Filed Jun 6, 2023 20:11 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 500 | $283.38 | $141,690.00 |
DisclosureSEC source: 0001127602-23-018036 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,350 Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:04 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016710 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,850 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2024 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:01 UTC | EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958 | GrantStock Option (right to buy) · Derivative | 16,253 | $0.00 Strike: $26.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017702 · doc4.xml · derivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,253 Underlying: Common Stock · 16,253 shares Expires 2033-03-07 F1 · derivative.exercise_date: The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:05 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015761 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:20 UTC | EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958 | GrantStock Option (right to buy) · Derivative | 11,200 | $0.00 Strike: $47.39 | $0.00 |
DisclosureSEC source: 0001209191-22-015030 · doc4.xml · derivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2032-02-28 F1 · derivative.exercise_date: The option fully vests on February 28, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 20:22 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 998 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027198 · form4.xml · nonDerivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998 F1 · shares: Initial equity award in the form of restricted stock units ("RSUs"). RSUs vest 50% on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant. The RSUs are settled in shares of common stock on a one-for-one basis. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 17:02 UTC | EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958 | GrantStock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $41.42 | $0.00 |
DisclosureSEC source: 0001209191-21-029334 · doc4.xml · derivative · entry 1 BORIO LUCIANA · CIK 0001859226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2031-04-28 F1 · derivative.exercise_date: One thirty-sixth (1/36th) of the shares underlying the option shall vest on each monthly anniversary of April 28, 2021 over the following three years, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.